Owner Amura Therapeutics Limited

Inventors Quibell, Martin

Agent Davies Collison Cave

Pub. Number AU-B-2002219397

PCT Pub. Number WO2002/057270

Priority 0101179.0 17.01.01 GB; 60/275,359 13.03.01 US

Filing date 17 January 2002

Wipo publication date 30 July 2002

Acceptance publication date 14 February 2008

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4178 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4439 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 33/00 (2006.01) Antiparasitic agents

A61P 33/02 (2006.01) Antiparasitic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 491/04 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 491/048 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations